US considers cutting Moderna doses in half for efficiency

Moderna vaccine half doses could be effective in speeding up roll out
Mgn 1280x960 00403p00 Fnyra

LINCOLN, Neb. (KLKN)- The FDA is meeting this week to consider giving half doses of Moderna’s COVID-19 vaccine to people ages 18-55.

The chief scientific advisor of Operation Warp Speed, Moncef Slaoui, says clinical data shows the vaccine can be just as effective at half the dose in that age group.

The effort to roll out the vaccine has been slower than expected. The original goal was to vaccinate 20 million Americans by the end of 2020.

So far, to date, only 4 million Americans have received their first dose of the two COVID-19 shots required.

SEE ALSO: UK ramps up inoculations with Oxford-AstraZeneca vaccine

Categories: Coronavirus, News